Effect of Maternal Body Mass Index on the Efficacy of Antenatal Betamethasone Administration in Neonatal Outcomes

Document Type : Original Article

Authors

1 Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Perinatology, Yas Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran and Maternal, Fetal, and Neonatal Research Center, Family Health Institute, Tehran University of Medical Sciences, Tehran, Iran

5 Department of Gynecology and Obstetrics, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

6 Department of Obstetrics and Gynecology, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

7 Perinatologist, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

8 Breastfeeding Research Center, Family Health Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Maternal obesity affects the health of infants and pregnancy outcomes. Few studies, to the best of our knowledge, have assessed the relationship between maternal body mass index (BMI) at antenatal corticosteroid therapy (ACS) and the frequency of preterm adverse outcomes results of which were discrepant. The present study aimed to investigate the prevalence of several neonatal morbidities based on maternal BMI among pregnant women who received a single course of ACS.
Methods: The present retrospective study was conducted on pregnant women referred to Mahdieh Hospital in Tehran, Iran between 2021 and 2022. Medical records of pregnant women were included who received a single course of betamethasone with the risk of preterm birth. The mothers were divided into three groups in terms of weight after checking the inclusion criteria. Clinical characteristics and neonatal outcomes were collected and analyzed using soft statistics.
Results: A total of 610 medical records (30.49%: normal weight, 57.54%: overweight, and 11.98%: obese) were included. Also, the cesarean section rate in overweight and obese cases was significantly higher than that of the normal BMI group (P<0.05). No significant relationship was observed between maternal BMI and neonatal mortality or morbidity (P> 0.05).
Conclusion: BMI was more associated with increased cesarean section rate in overweight and obese groups. However, no significant relationship was observed between maternal BMI and neonatal outcomes. This result suggests that BMI fails to affect the efficacy of betamethasone.
 
 

Keywords

References

  1. Hamilton BE, Martin JA, Osterman MJ. Births: provisional data for 2020. 2021; 70(17):1-50.
  2. Delorme P, Goffinet F, Ancel PY, Foix LHelias L, Langer B, Lebeaux C, et al. Cause of preterm birth as a prognostic factor for mortality. Obstet Gynecol. 2016; 127(1):40-8.
  3. McDonald SD, Han Z, Mulla S, Beyene J, Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. Bmj. 2010; 341:3428.
  4. Liu B, Xu G, Sun Y, Du Y, Gao R, Snetselaar LG, et al. Association between maternal pre-pregnancy obesity and preterm birth according to maternal age and race or ethnicity: a population-based study. Lancet Diabetes Endocrinol. 2019; 7(9):707-14.
  5. Torloni MR, Betran AP, Daher S, Widmer M, Dolan SM, Menon R, et al. Maternal BMI, and preterm birth: a systematic review of the literature with meta-analysis. J Matern Fetal Neonatal Med. 2009; 22(11):957-70.
  6. Salihu H, Mbah AK, Alio AP, Kornosky JL, Whiteman VE, Belogolovkin V, et al. Nulliparity and preterm birth in the era of obesity epidemic. J Matern Fetal Neonatal Med. 2010; 23(12):1444-50.
  7. Raisanen S, Gissler M, Saari J, Kramer M, Heinonen S. Contribution of risk factors to extremely, very and moderately preterm births–register-based analysis of 1,390,742 singleton births. PLoS One. 2013; 8(4):1-7.
  8. Cnattingius S, Villamor E, Johansson S, Bonamy AKE, Persson M, Wikstrom AK, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013; 309(22):
    2362-70.
  9. Bonanno C, Wapner RJ. Antenatal corticosteroid treatment: what's happened since Drs Liggins and Howie? Am J Obstet Gynecol. 2009; 200(4):448-57.
  10. Bicocca MJ, Blackwell SC, Sibai BM. Does prepregnancy weight or maternal BMI at betamethasone administration impact late preterm respiratory morbidity? Am J Perinatol. 2020; 37(4):365-9.
  11. Gyamfi C, Mele L, Wapner RJ, Spong CY, Peaceman A, Sorokin Y, et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol. 2010; 203(3):219-5.
  12. Hashima JN, Lai Y, Wapner RJ, Sorokin Y, Dudley DJ, Peaceman A, et al. The effect of maternal body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids. Am J Obstet Gynecol. 2010; 202(3):263-5.
  13. Della Torre M, Hibbard JU, Jeong H, Fischer JH. Betamethasone in pregnancy: influence of maternal body weight and multiple gestations on pharmacokinetics. Am J Obstet Gynecol. 2010; 203(3):254-12.
  14. Faden M, McDonald SD, Shah PS, Mukerji A. Impact of antenatal corticosteroids in preterm neonates based on maternal body mass index. J Perinatol. 2018; 38(7):813-9.
  15. Bjorklund J, Wiberg Itzel E, Wallstrom T. Is there an increased risk of cesarean section in obese women after induction of labor? A retrospective cohort study. PloS One. 2022; 17(2):1-10.
  16. Machado LS. Cesarean section in morbidly obese parturients: practical implications and complications. N Am J Med Sci. 2012; 4(1):13-8.
  17. Dasgupta S, Roy P, Ghosh C, Biswas J, Das P, Ghosh U, et al. A prospective cohort study of adverse fetomaternal outcomes among overweight, obese, and normal weight pregnant women with term singleton pregnancy in a tertiary care hospital. Asian J Med Sci. 2022; 13(4):106-11.
  18. Fallatah AM, Babatin HM, Nassibi KM, Banweer MK, FayoumiMN, Oraif AM. Maternal and neonatal outcomes among obese pregnant women in King Abdulaziz University Hospital: a retrospective single-center medical record review. Med Arch. 2019; 73(6):425-32.
  19. Fayed A, Wahabi HA, Esmaeil S, Elkouny R, Elmorshedy H, Bakhsh H. Independent effect of gestational weight gain and prepregnancy obesity on pregnancy outcomes among Saudi women: A sub-cohort analysis from Riyadh mother and baby cohort study (RAHMA). PloS One. 2022; 17(1):1-14.
  20. Salim R, Suleiman A, Colodner R, Nachum Z, Goldstein LH, Shalev E. Measurement of betamethasone concentration in maternal serum treated for fetal lung maturity; Is it feasible? Reprod Biol Endocrinol. 2016; 14(1):1-5.
Iranian Journal of Neonatology
Volume 13, Issue 3
July 2022
Pages 21-28

Files

Share

How to cite

Statistics